Sotac Pharma. — 360° view

Sotac Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹77 crore and net profit of ₹5.00 crore for the September 2026 quarter.

Sotac Pharma. (NSE: SOTAC-SM) closed at ₹135.00 on 20 Nov 2026, up 8.0% over the past year. Its market capitalisation is ₹149 crore and it trades at 17.2 times earnings.

Share price
₹135.00 (20 Nov 2026)
Market cap
₹149 Cr (20 Nov 2026)
P/E
17.17 (20 Nov 2026)
Revenue
₹77 Cr (September 2026 quarter)
Net profit
₹5 Cr (September 2026 quarter)
ROCE
12.5% (FY26)
ROE
10.1% (FY26)
Book value
₹58.1 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹139.65 / ₹86.00 (20 Nov 2026)
1-year return
8.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SOTAC-SM

Incorporated in 2015, Sotac Pharmaceuticals Ltd manufactures and sells a wide range of pharmaceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.